Novel antifungal drugs
- 1 October 1999
- journal article
- review article
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 2 (5) , 509-515
- https://doi.org/10.1016/s1369-5274(99)00009-0
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- An aureobasidin A resistance gene isolated from Aspergillus is a homolog of yeast AUR1, a gene responsible for inositol phosphorylceramide (IPC) synthase activityMolecular Genetics and Genomics, 1999
- Detection and Analysis of Translation Elongation Factor 3 Genes from Various YeastsBioscience, Biotechnology, and Biochemistry, 1999
- Ribosomal P-protein Stalk Function Is Targeted by Sordarin AntifungalsPublished by Elsevier ,1998
- In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvinMycoses, 1998
- Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.Diagnostic Microbiology and Infectious Disease, 1998
- In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin BJournal of Antimicrobial Chemotherapy, 1998
- Novel Biologically Active Nonpeptidic Inhibitors of MyristoylCoA:Protein N-MyristoyltransferaseJournal of Medicinal Chemistry, 1998
- Design and Synthesis of Novel Imidazole-Substituted Dipeptide Amides as Potent and Selective Inhibitors of Candida albicans MyristoylCoA:Protein N-Myristoyltransferase and Identification of Related Tripeptide Inhibitors with Mechanism-Based Antifungal ActivityJournal of Medicinal Chemistry, 1997
- Antifungals targeted to the cell wallExpert Opinion on Investigational Drugs, 1997
- Genetic studies reveal that myristoylCoA:protein N‐myristoyltransferase is an essential enzyme in Candida albicansMolecular Microbiology, 1995